Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,146 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,359
Recruiting: 791
Ph III recruiting: 74
Growth YoY: +9.7%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (645)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05634720	Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer	active not recruiting	Phase 4	20	Duke UniversityOTHER	1	Jan 26, 2026	clinicaltrials
NCT03024684	Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment(SHOT)	active not recruiting	Phase 4	240	Chiayi Christian HospitalOTHER	1	Nov 12, 2024	clinicaltrials